Piper Jaffray upgraded BioMarin Pharmaceutical (NASDAQ: BMRN) from Neutral to Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE